Feasibility of interstitial stepping-source electronic brachytherapy to locally inoperable tumors

TitleFeasibility of interstitial stepping-source electronic brachytherapy to locally inoperable tumors
Publication TypeJournal Article
Year of Publication2020
AuthorsRuder, AMathias, Inghelram, L, Schneider, F, Sarria, GR, Hesser, J, Bludau, F, Obertacke, U, Wenz, F, Abo-Madyan, Y, Giordano, FA
JournalJournal of Contemporary Brachytherapy
Volume12
Pagination480–486
ISSN1689-832X
Abstract

Purpose Radiotherapy is the mainstay in the treatment of locally inoperable tumors. Interstitial electronic needle-based kilovoltage brachytherapy (EBT) could be an economic alternative to high-dose-rate (HDR) brachytherapy or permanent seed implantation (PSI). In this work, we evaluated if locally inoperable tumors treated with PSI at our institution may be suitable for EBT. Material and methods A total of 10 post-interventional computed tomography (CT) scans of patients, who received PSI and simulated stepping-source EBT applied with Intrabeam system and needle applicator were used. EBT treatment planning software with 3-dimensional image and projection of applicator were applied for designing trajectories and establishing dwell positions. Dwell position doses were summarized, and doses covering 90% of the target volume (D90) achieved with stepping-source EBT were compared to those of PSI. Additionally, conformality of dose distributions and total irradiation time were assessed using conformation number (CN) or conformal index (COIN). Results In all patients, D90 of EBT exceeded the prescribed dose or D90 of PSI on average by 4.7% or 21.3% relative to the prescribed dose, respectively. Mean number of trajectories was 5.0 for EBT and 6.9 for PSI. Average CN/COIN for EBT was 0.69, with a mean irradiation time of 27.8 minutes for standardized dose of 13 Gy. Conclusions Stepping-source EBT allowed for a conformal treatment of inoperable interstitial tumors with similar D90. Fewer trajectories were required for EBT in majority of cases.

URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701928/
DOI10.5114/jcb.2020.100381
Citation Keyruder_feasibility_2020
PubMed ID33299437